Metabolic syndrome and prostate cancer.
Glode
L Michael
LM
D052242:Adiponectin / Q000097:blood; D000273:Adipose Tissue / Q000187:drug effects; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects* / Q000627:therapeutic use; D015992:Body Mass Index; D001835:Body Weight / Q000187:drug effects; D008076:Cholesterol, HDL / Q000097:blood; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists*; D006801:Humans; D016729:Leuprolide / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D024821:Metabolic Syndrome / Q000139:chemically induced*; D011471:Prostatic Neoplasms / Q000188:drug therapy*
D052242:Adiponectin; D018931:Antineoplastic Agents, Hormonal; D008076:Cholesterol, HDL; D007987:Gonadotropin-Releasing Hormone; D016729:Leuprolide